Skip to main content
. 2015 May 14;15:403. doi: 10.1186/s12885-015-1423-6

Table 3.

Comparison of primary tumor and metastatic tissue by HER2 status (PRIM-HER2 and MET-HER2 status, respectively)

Total MET-HER2-negative MET-HER2-positive
PRIM-HER2 status (total) 46 (100 %) 40/46 (87 %) 6/46 (13 %)
 Negative 42/46 (91 %) 37/42 (88 %) 5/42 (12 %)
 Positive 4/46 (9 %) 3/4 (7 %) 1/4 (25 %)

Overall accuracy of MET-HER2 and PRIM-HER2 status: 83 %